nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—CYP2A6—stomach cancer	0.552	1	CbGaD
Amphetamine—SLC22A3—Irinotecan—stomach cancer	0.13	0.652	CbGbCtD
Amphetamine—CYP2A6—Fluorouracil—stomach cancer	0.0589	0.295	CbGbCtD
Amphetamine—CYP2D6—Doxorubicin—stomach cancer	0.0106	0.0529	CbGbCtD
Amphetamine—CARTPT—hematopoietic system—stomach cancer	0.00489	0.14	CbGeAlD
Amphetamine—CARTPT—lymphoid tissue—stomach cancer	0.00344	0.0985	CbGeAlD
Amphetamine—CARTPT—endocrine gland—stomach cancer	0.00281	0.0804	CbGeAlD
Amphetamine—Phenformin—PRKAA1—stomach cancer	0.00235	0.353	CrCbGaD
Amphetamine—CARTPT—lymph node—stomach cancer	0.00194	0.0556	CbGeAlD
Amphetamine—SLC18A2—hematopoietic system—stomach cancer	0.00166	0.0476	CbGeAlD
Amphetamine—SLC6A3—hematopoietic system—stomach cancer	0.00126	0.036	CbGeAlD
Amphetamine—SLC22A3—hematopoietic system—stomach cancer	0.00118	0.0339	CbGeAlD
Amphetamine—SLC18A2—digestive system—stomach cancer	0.00116	0.0331	CbGeAlD
Amphetamine—SLC6A4—hematopoietic system—stomach cancer	0.00115	0.033	CbGeAlD
Amphetamine—MAOB—hematopoietic system—stomach cancer	0.00109	0.0313	CbGeAlD
Amphetamine—SLC22A3—smooth muscle tissue—stomach cancer	0.00104	0.0298	CbGeAlD
Amphetamine—SLC18A2—endocrine gland—stomach cancer	0.000955	0.0273	CbGeAlD
Amphetamine—SLC18A2—liver—stomach cancer	0.000861	0.0246	CbGeAlD
Amphetamine—SLC6A4—digestive system—stomach cancer	0.000801	0.0229	CbGeAlD
Amphetamine—CYP2A6—liver—stomach cancer	0.000769	0.022	CbGeAlD
Amphetamine—MAOB—digestive system—stomach cancer	0.000761	0.0218	CbGeAlD
Amphetamine—SLC22A3—endocrine gland—stomach cancer	0.00068	0.0195	CbGeAlD
Amphetamine—SLC6A4—endocrine gland—stomach cancer	0.000662	0.0189	CbGeAlD
Amphetamine—SLC18A2—lymph node—stomach cancer	0.00066	0.0189	CbGeAlD
Amphetamine—Lacosamide—CA1—stomach cancer	0.000646	0.0968	CrCbGaD
Amphetamine—MAOB—endocrine gland—stomach cancer	0.000629	0.018	CbGeAlD
Amphetamine—SLC22A3—liver—stomach cancer	0.000613	0.0175	CbGeAlD
Amphetamine—SLC22A5—digestive system—stomach cancer	0.000598	0.0171	CbGeAlD
Amphetamine—SLC6A2—endocrine gland—stomach cancer	0.000583	0.0167	CbGeAlD
Amphetamine—MAOB—liver—stomach cancer	0.000567	0.0162	CbGeAlD
Amphetamine—CYP2D6—hematopoietic system—stomach cancer	0.000555	0.0159	CbGeAlD
Amphetamine—DRD2—endocrine gland—stomach cancer	0.000531	0.0152	CbGeAlD
Amphetamine—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.0005	0.00414	CcSEcCtD
Amphetamine—Abdominal pain upper—Capecitabine—stomach cancer	0.000491	0.00406	CcSEcCtD
Amphetamine—Lacosamide—CA2—stomach cancer	0.000489	0.0734	CrCbGaD
Amphetamine—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.000484	0.00401	CcSEcCtD
Amphetamine—SLC22A3—lymph node—stomach cancer	0.00047	0.0135	CbGeAlD
Amphetamine—SLC22A5—liver—stomach cancer	0.000446	0.0128	CbGeAlD
Amphetamine—MAOB—lymph node—stomach cancer	0.000435	0.0124	CbGeAlD
Amphetamine—Weight decreased—Docetaxel—stomach cancer	0.000434	0.00359	CcSEcCtD
Amphetamine—Tranylcypromine—CYP2A6—stomach cancer	0.000426	0.0639	CrCbGaD
Amphetamine—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000424	0.00351	CcSEcCtD
Amphetamine—Photosensitivity reaction—Capecitabine—stomach cancer	0.000424	0.00351	CcSEcCtD
Amphetamine—Acute coronary syndrome—Docetaxel—stomach cancer	0.000422	0.00349	CcSEcCtD
Amphetamine—Weight decreased—Capecitabine—stomach cancer	0.00042	0.00348	CcSEcCtD
Amphetamine—Myocardial infarction—Docetaxel—stomach cancer	0.000419	0.00347	CcSEcCtD
Amphetamine—Hypertension—Irinotecan—stomach cancer	0.000418	0.00346	CcSEcCtD
Amphetamine—Depression—Capecitabine—stomach cancer	0.000413	0.00342	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000411	0.0034	CcSEcCtD
Amphetamine—Acute coronary syndrome—Capecitabine—stomach cancer	0.000408	0.00338	CcSEcCtD
Amphetamine—Cerebrovascular accident—Methotrexate—stomach cancer	0.000408	0.00338	CcSEcCtD
Amphetamine—Myocardial infarction—Capecitabine—stomach cancer	0.000406	0.00336	CcSEcCtD
Amphetamine—SLC6A2—lymph node—stomach cancer	0.000403	0.0115	CbGeAlD
Amphetamine—Urinary tract infection—Capecitabine—stomach cancer	0.000403	0.00333	CcSEcCtD
Amphetamine—Convulsion—Fluorouracil—stomach cancer	0.000401	0.00332	CcSEcCtD
Amphetamine—Anaphylactic shock—Irinotecan—stomach cancer	0.000395	0.00327	CcSEcCtD
Amphetamine—Chest pain—Fluorouracil—stomach cancer	0.000394	0.00326	CcSEcCtD
Amphetamine—Infection—Irinotecan—stomach cancer	0.000392	0.00324	CcSEcCtD
Amphetamine—Phenylpropanolamine—ADRB1—stomach cancer	0.000389	0.0584	CrCbGaD
Amphetamine—CYP2D6—digestive system—stomach cancer	0.000386	0.011	CbGeAlD
Amphetamine—Cerebrovascular accident—Epirubicin—stomach cancer	0.000382	0.00316	CcSEcCtD
Amphetamine—Irritability—Methotrexate—stomach cancer	0.000382	0.00316	CcSEcCtD
Amphetamine—Hyperhidrosis—Irinotecan—stomach cancer	0.000382	0.00316	CcSEcCtD
Amphetamine—Mood swings—Methotrexate—stomach cancer	0.000379	0.00314	CcSEcCtD
Amphetamine—Anaphylactic shock—Fluorouracil—stomach cancer	0.000378	0.00313	CcSEcCtD
Amphetamine—Anorexia—Irinotecan—stomach cancer	0.000376	0.00311	CcSEcCtD
Amphetamine—Infection—Fluorouracil—stomach cancer	0.000376	0.00311	CcSEcCtD
Amphetamine—Tachycardia—Fluorouracil—stomach cancer	0.000369	0.00305	CcSEcCtD
Amphetamine—Affect lability—Epirubicin—stomach cancer	0.000369	0.00305	CcSEcCtD
Amphetamine—Ephedrine—ADRB2—stomach cancer	0.000365	0.0548	CrCbGaD
Amphetamine—Erythema multiforme—Docetaxel—stomach cancer	0.000363	0.003	CcSEcCtD
Amphetamine—Anorexia—Fluorouracil—stomach cancer	0.00036	0.00298	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.00036	0.00298	CcSEcCtD
Amphetamine—Insomnia—Irinotecan—stomach cancer	0.000357	0.00295	CcSEcCtD
Amphetamine—Mood swings—Epirubicin—stomach cancer	0.000355	0.00294	CcSEcCtD
Amphetamine—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000354	0.00293	CcSEcCtD
Amphetamine—Dyspnoea—Irinotecan—stomach cancer	0.000352	0.00291	CcSEcCtD
Amphetamine—Erythema multiforme—Capecitabine—stomach cancer	0.000352	0.00291	CcSEcCtD
Amphetamine—Somnolence—Irinotecan—stomach cancer	0.000351	0.0029	CcSEcCtD
Amphetamine—Dyspepsia—Irinotecan—stomach cancer	0.000348	0.00288	CcSEcCtD
Amphetamine—Decreased appetite—Irinotecan—stomach cancer	0.000343	0.00284	CcSEcCtD
Amphetamine—Abdominal pain upper—Epirubicin—stomach cancer	0.000342	0.00283	CcSEcCtD
Amphetamine—Insomnia—Fluorouracil—stomach cancer	0.000342	0.00283	CcSEcCtD
Amphetamine—SLC22A5—lymph node—stomach cancer	0.000342	0.00978	CbGeAlD
Amphetamine—Affect lability—Doxorubicin—stomach cancer	0.000341	0.00282	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000341	0.00282	CcSEcCtD
Amphetamine—Fatigue—Irinotecan—stomach cancer	0.00034	0.00282	CcSEcCtD
Amphetamine—Constipation—Irinotecan—stomach cancer	0.000338	0.00279	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000337	0.00279	CcSEcCtD
Amphetamine—Dyspnoea—Fluorouracil—stomach cancer	0.000337	0.00279	CcSEcCtD
Amphetamine—Somnolence—Fluorouracil—stomach cancer	0.000336	0.00278	CcSEcCtD
Amphetamine—Dyspepsia—Fluorouracil—stomach cancer	0.000333	0.00275	CcSEcCtD
Amphetamine—Selegiline—CYP2A6—stomach cancer	0.000331	0.0496	CrCbGaD
Amphetamine—Pseudoephedrine—ADRB1—stomach cancer	0.000329	0.0493	CrCbGaD
Amphetamine—Decreased appetite—Fluorouracil—stomach cancer	0.000329	0.00272	CcSEcCtD
Amphetamine—Mood swings—Doxorubicin—stomach cancer	0.000328	0.00272	CcSEcCtD
Amphetamine—Phenylpropanolamine—ADRB2—stomach cancer	0.000327	0.0491	CrCbGaD
Amphetamine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000326	0.0027	CcSEcCtD
Amphetamine—Gastrointestinal pain—Irinotecan—stomach cancer	0.000323	0.00267	CcSEcCtD
Amphetamine—CYP2D6—endocrine gland—stomach cancer	0.000319	0.00913	CbGeAlD
Amphetamine—Erectile dysfunction—Methotrexate—stomach cancer	0.000319	0.00264	CcSEcCtD
Amphetamine—Abdominal pain upper—Doxorubicin—stomach cancer	0.000317	0.00262	CcSEcCtD
Amphetamine—Photosensitivity reaction—Methotrexate—stomach cancer	0.000316	0.00261	CcSEcCtD
Amphetamine—Body temperature increased—Irinotecan—stomach cancer	0.000312	0.00258	CcSEcCtD
Amphetamine—Abdominal pain—Irinotecan—stomach cancer	0.000312	0.00258	CcSEcCtD
Amphetamine—Pseudoephedrine—TNF—stomach cancer	0.000312	0.0468	CrCbGaD
Amphetamine—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000312	0.00258	CcSEcCtD
Amphetamine—Depression—Methotrexate—stomach cancer	0.000308	0.00254	CcSEcCtD
Amphetamine—Nateglinide—PPARG—stomach cancer	0.000306	0.046	CrCbGaD
Amphetamine—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000306	0.00253	CcSEcCtD
Amphetamine—Tremor—Capecitabine—stomach cancer	0.000303	0.00251	CcSEcCtD
Amphetamine—Urticaria—Fluorouracil—stomach cancer	0.0003	0.00249	CcSEcCtD
Amphetamine—Body temperature increased—Fluorouracil—stomach cancer	0.000299	0.00247	CcSEcCtD
Amphetamine—Sweating—Methotrexate—stomach cancer	0.000296	0.00245	CcSEcCtD
Amphetamine—Palpitations—Docetaxel—stomach cancer	0.000296	0.00244	CcSEcCtD
Amphetamine—Photosensitivity reaction—Epirubicin—stomach cancer	0.000295	0.00244	CcSEcCtD
Amphetamine—Weight decreased—Epirubicin—stomach cancer	0.000293	0.00242	CcSEcCtD
Amphetamine—Hypersensitivity—Irinotecan—stomach cancer	0.000291	0.00241	CcSEcCtD
Amphetamine—Convulsion—Docetaxel—stomach cancer	0.00029	0.0024	CcSEcCtD
Amphetamine—Hypertension—Docetaxel—stomach cancer	0.000289	0.00239	CcSEcCtD
Amphetamine—CYP2D6—liver—stomach cancer	0.000288	0.00823	CbGeAlD
Amphetamine—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000286	0.00237	CcSEcCtD
Amphetamine—Palpitations—Capecitabine—stomach cancer	0.000286	0.00237	CcSEcCtD
Amphetamine—Chest pain—Docetaxel—stomach cancer	0.000285	0.00236	CcSEcCtD
Amphetamine—Asthenia—Irinotecan—stomach cancer	0.000283	0.00234	CcSEcCtD
Amphetamine—Urinary tract infection—Epirubicin—stomach cancer	0.000281	0.00232	CcSEcCtD
Amphetamine—Hypertension—Capecitabine—stomach cancer	0.00028	0.00231	CcSEcCtD
Amphetamine—Hypersensitivity—Fluorouracil—stomach cancer	0.000279	0.0023	CcSEcCtD
Amphetamine—Dry mouth—Docetaxel—stomach cancer	0.000278	0.0023	CcSEcCtD
Amphetamine—Sweating—Epirubicin—stomach cancer	0.000277	0.00229	CcSEcCtD
Amphetamine—Pseudoephedrine—ADRB2—stomach cancer	0.000277	0.0415	CrCbGaD
Amphetamine—Chest pain—Capecitabine—stomach cancer	0.000276	0.00228	CcSEcCtD
Amphetamine—Anxiety—Capecitabine—stomach cancer	0.000275	0.00227	CcSEcCtD
Amphetamine—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000273	0.00226	CcSEcCtD
Amphetamine—Anaphylactic shock—Docetaxel—stomach cancer	0.000273	0.00226	CcSEcCtD
Amphetamine—Infection—Docetaxel—stomach cancer	0.000271	0.00224	CcSEcCtD
Amphetamine—Weight decreased—Doxorubicin—stomach cancer	0.000271	0.00224	CcSEcCtD
Amphetamine—Diarrhoea—Irinotecan—stomach cancer	0.00027	0.00223	CcSEcCtD
Amphetamine—Dry mouth—Capecitabine—stomach cancer	0.00027	0.00223	CcSEcCtD
Amphetamine—Tachycardia—Docetaxel—stomach cancer	0.000266	0.0022	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000265	0.00219	CcSEcCtD
Amphetamine—Infection—Capecitabine—stomach cancer	0.000263	0.00217	CcSEcCtD
Amphetamine—Erythema multiforme—Methotrexate—stomach cancer	0.000262	0.00217	CcSEcCtD
Amphetamine—Dizziness—Irinotecan—stomach cancer	0.000261	0.00216	CcSEcCtD
Amphetamine—Anorexia—Docetaxel—stomach cancer	0.00026	0.00215	CcSEcCtD
Amphetamine—Urinary tract infection—Doxorubicin—stomach cancer	0.00026	0.00215	CcSEcCtD
Amphetamine—Diarrhoea—Fluorouracil—stomach cancer	0.000259	0.00214	CcSEcCtD
Amphetamine—Tachycardia—Capecitabine—stomach cancer	0.000258	0.00213	CcSEcCtD
Amphetamine—Sweating—Doxorubicin—stomach cancer	0.000256	0.00212	CcSEcCtD
Amphetamine—Hyperhidrosis—Capecitabine—stomach cancer	0.000255	0.00211	CcSEcCtD
Amphetamine—Anorexia—Capecitabine—stomach cancer	0.000252	0.00208	CcSEcCtD
Amphetamine—Vomiting—Irinotecan—stomach cancer	0.000251	0.00208	CcSEcCtD
Amphetamine—Dizziness—Fluorouracil—stomach cancer	0.00025	0.00207	CcSEcCtD
Amphetamine—Rash—Irinotecan—stomach cancer	0.000249	0.00206	CcSEcCtD
Amphetamine—Dermatitis—Irinotecan—stomach cancer	0.000249	0.00206	CcSEcCtD
Amphetamine—Headache—Irinotecan—stomach cancer	0.000247	0.00205	CcSEcCtD
Amphetamine—Insomnia—Docetaxel—stomach cancer	0.000247	0.00204	CcSEcCtD
Amphetamine—Erythema multiforme—Epirubicin—stomach cancer	0.000245	0.00203	CcSEcCtD
Amphetamine—Dyspnoea—Docetaxel—stomach cancer	0.000243	0.00201	CcSEcCtD
Amphetamine—Somnolence—Docetaxel—stomach cancer	0.000243	0.00201	CcSEcCtD
Amphetamine—Vomiting—Fluorouracil—stomach cancer	0.00024	0.00199	CcSEcCtD
Amphetamine—Dyspepsia—Docetaxel—stomach cancer	0.00024	0.00199	CcSEcCtD
Amphetamine—Insomnia—Capecitabine—stomach cancer	0.000239	0.00198	CcSEcCtD
Amphetamine—Rash—Fluorouracil—stomach cancer	0.000238	0.00197	CcSEcCtD
Amphetamine—Dermatitis—Fluorouracil—stomach cancer	0.000238	0.00197	CcSEcCtD
Amphetamine—Decreased appetite—Docetaxel—stomach cancer	0.000237	0.00196	CcSEcCtD
Amphetamine—Headache—Fluorouracil—stomach cancer	0.000237	0.00196	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000236	0.00195	CcSEcCtD
Amphetamine—Dyspnoea—Capecitabine—stomach cancer	0.000236	0.00195	CcSEcCtD
Amphetamine—Fatigue—Docetaxel—stomach cancer	0.000235	0.00195	CcSEcCtD
Amphetamine—Nausea—Irinotecan—stomach cancer	0.000235	0.00194	CcSEcCtD
Amphetamine—Constipation—Docetaxel—stomach cancer	0.000233	0.00193	CcSEcCtD
Amphetamine—Dyspepsia—Capecitabine—stomach cancer	0.000233	0.00192	CcSEcCtD
Amphetamine—Decreased appetite—Capecitabine—stomach cancer	0.00023	0.0019	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000228	0.00189	CcSEcCtD
Amphetamine—Fatigue—Capecitabine—stomach cancer	0.000228	0.00188	CcSEcCtD
Amphetamine—Erythema multiforme—Doxorubicin—stomach cancer	0.000227	0.00188	CcSEcCtD
Amphetamine—Constipation—Capecitabine—stomach cancer	0.000226	0.00187	CcSEcCtD
Amphetamine—Nausea—Fluorouracil—stomach cancer	0.000225	0.00186	CcSEcCtD
Amphetamine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000223	0.00185	CcSEcCtD
Amphetamine—Tension—Epirubicin—stomach cancer	0.000221	0.00183	CcSEcCtD
Amphetamine—Nervousness—Epirubicin—stomach cancer	0.000219	0.00181	CcSEcCtD
Amphetamine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000216	0.00179	CcSEcCtD
Amphetamine—Body temperature increased—Docetaxel—stomach cancer	0.000216	0.00178	CcSEcCtD
Amphetamine—Abdominal pain—Docetaxel—stomach cancer	0.000216	0.00178	CcSEcCtD
Amphetamine—Urticaria—Capecitabine—stomach cancer	0.00021	0.00174	CcSEcCtD
Amphetamine—Abdominal pain—Capecitabine—stomach cancer	0.000209	0.00173	CcSEcCtD
Amphetamine—Body temperature increased—Capecitabine—stomach cancer	0.000209	0.00173	CcSEcCtD
Amphetamine—Convulsion—Methotrexate—stomach cancer	0.000209	0.00173	CcSEcCtD
Amphetamine—Agitation—Epirubicin—stomach cancer	0.000207	0.00171	CcSEcCtD
Amphetamine—Chest pain—Methotrexate—stomach cancer	0.000205	0.0017	CcSEcCtD
Amphetamine—Tension—Doxorubicin—stomach cancer	0.000205	0.00169	CcSEcCtD
Amphetamine—Nervousness—Doxorubicin—stomach cancer	0.000203	0.00168	CcSEcCtD
Amphetamine—Hypersensitivity—Docetaxel—stomach cancer	0.000201	0.00166	CcSEcCtD
Amphetamine—Palpitations—Epirubicin—stomach cancer	0.000199	0.00165	CcSEcCtD
Amphetamine—Anaphylactic shock—Methotrexate—stomach cancer	0.000197	0.00163	CcSEcCtD
Amphetamine—Asthenia—Docetaxel—stomach cancer	0.000196	0.00162	CcSEcCtD
Amphetamine—Convulsion—Epirubicin—stomach cancer	0.000195	0.00162	CcSEcCtD
Amphetamine—Infection—Methotrexate—stomach cancer	0.000195	0.00162	CcSEcCtD
Amphetamine—Hypertension—Epirubicin—stomach cancer	0.000195	0.00161	CcSEcCtD
Amphetamine—Hypersensitivity—Capecitabine—stomach cancer	0.000195	0.00161	CcSEcCtD
Amphetamine—Chest pain—Epirubicin—stomach cancer	0.000192	0.00159	CcSEcCtD
Amphetamine—Agitation—Doxorubicin—stomach cancer	0.000192	0.00159	CcSEcCtD
Amphetamine—Anxiety—Epirubicin—stomach cancer	0.000191	0.00158	CcSEcCtD
Amphetamine—Hyperhidrosis—Methotrexate—stomach cancer	0.00019	0.00157	CcSEcCtD
Amphetamine—Asthenia—Capecitabine—stomach cancer	0.00019	0.00157	CcSEcCtD
Amphetamine—Dry mouth—Epirubicin—stomach cancer	0.000188	0.00155	CcSEcCtD
Amphetamine—Anorexia—Methotrexate—stomach cancer	0.000188	0.00155	CcSEcCtD
Amphetamine—Diarrhoea—Docetaxel—stomach cancer	0.000187	0.00154	CcSEcCtD
Amphetamine—Palpitations—Doxorubicin—stomach cancer	0.000184	0.00153	CcSEcCtD
Amphetamine—Anaphylactic shock—Epirubicin—stomach cancer	0.000184	0.00152	CcSEcCtD
Amphetamine—Infection—Epirubicin—stomach cancer	0.000183	0.00151	CcSEcCtD
Amphetamine—Convulsion—Doxorubicin—stomach cancer	0.000181	0.0015	CcSEcCtD
Amphetamine—Diarrhoea—Capecitabine—stomach cancer	0.000181	0.0015	CcSEcCtD
Amphetamine—Dizziness—Docetaxel—stomach cancer	0.00018	0.00149	CcSEcCtD
Amphetamine—Hypertension—Doxorubicin—stomach cancer	0.00018	0.00149	CcSEcCtD
Amphetamine—Tachycardia—Epirubicin—stomach cancer	0.00018	0.00149	CcSEcCtD
Amphetamine—Hyperhidrosis—Epirubicin—stomach cancer	0.000178	0.00147	CcSEcCtD
Amphetamine—Insomnia—Methotrexate—stomach cancer	0.000178	0.00147	CcSEcCtD
Amphetamine—Chest pain—Doxorubicin—stomach cancer	0.000178	0.00147	CcSEcCtD
Amphetamine—Anxiety—Doxorubicin—stomach cancer	0.000177	0.00146	CcSEcCtD
Amphetamine—Anorexia—Epirubicin—stomach cancer	0.000175	0.00145	CcSEcCtD
Amphetamine—Dyspnoea—Methotrexate—stomach cancer	0.000175	0.00145	CcSEcCtD
Amphetamine—Somnolence—Methotrexate—stomach cancer	0.000175	0.00145	CcSEcCtD
Amphetamine—Dizziness—Capecitabine—stomach cancer	0.000175	0.00145	CcSEcCtD
Amphetamine—Dry mouth—Doxorubicin—stomach cancer	0.000174	0.00144	CcSEcCtD
Amphetamine—Vomiting—Docetaxel—stomach cancer	0.000174	0.00144	CcSEcCtD
Amphetamine—Dyspepsia—Methotrexate—stomach cancer	0.000173	0.00143	CcSEcCtD
Amphetamine—Rash—Docetaxel—stomach cancer	0.000172	0.00142	CcSEcCtD
Amphetamine—Dermatitis—Docetaxel—stomach cancer	0.000172	0.00142	CcSEcCtD
Amphetamine—Decreased appetite—Methotrexate—stomach cancer	0.000171	0.00141	CcSEcCtD
Amphetamine—Headache—Docetaxel—stomach cancer	0.000171	0.00141	CcSEcCtD
Amphetamine—Anaphylactic shock—Doxorubicin—stomach cancer	0.00017	0.00141	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00017	0.0014	CcSEcCtD
Amphetamine—Fatigue—Methotrexate—stomach cancer	0.00017	0.0014	CcSEcCtD
Amphetamine—Infection—Doxorubicin—stomach cancer	0.000169	0.0014	CcSEcCtD
Amphetamine—Vomiting—Capecitabine—stomach cancer	0.000168	0.00139	CcSEcCtD
Amphetamine—Rash—Capecitabine—stomach cancer	0.000167	0.00138	CcSEcCtD
Amphetamine—Insomnia—Epirubicin—stomach cancer	0.000167	0.00138	CcSEcCtD
Amphetamine—Dermatitis—Capecitabine—stomach cancer	0.000166	0.00138	CcSEcCtD
Amphetamine—Tachycardia—Doxorubicin—stomach cancer	0.000166	0.00138	CcSEcCtD
Amphetamine—Headache—Capecitabine—stomach cancer	0.000166	0.00137	CcSEcCtD
Amphetamine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000165	0.00136	CcSEcCtD
Amphetamine—Dyspnoea—Epirubicin—stomach cancer	0.000164	0.00136	CcSEcCtD
Amphetamine—Somnolence—Epirubicin—stomach cancer	0.000164	0.00135	CcSEcCtD
Amphetamine—Anorexia—Doxorubicin—stomach cancer	0.000162	0.00134	CcSEcCtD
Amphetamine—Nausea—Docetaxel—stomach cancer	0.000162	0.00134	CcSEcCtD
Amphetamine—Dyspepsia—Epirubicin—stomach cancer	0.000162	0.00134	CcSEcCtD
Amphetamine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000161	0.00133	CcSEcCtD
Amphetamine—Decreased appetite—Epirubicin—stomach cancer	0.00016	0.00132	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000159	0.00131	CcSEcCtD
Amphetamine—Fatigue—Epirubicin—stomach cancer	0.000159	0.00131	CcSEcCtD
Amphetamine—Constipation—Epirubicin—stomach cancer	0.000157	0.0013	CcSEcCtD
Amphetamine—Nausea—Capecitabine—stomach cancer	0.000157	0.0013	CcSEcCtD
Amphetamine—Urticaria—Methotrexate—stomach cancer	0.000156	0.00129	CcSEcCtD
Amphetamine—Abdominal pain—Methotrexate—stomach cancer	0.000156	0.00129	CcSEcCtD
Amphetamine—Body temperature increased—Methotrexate—stomach cancer	0.000156	0.00129	CcSEcCtD
Amphetamine—Insomnia—Doxorubicin—stomach cancer	0.000154	0.00127	CcSEcCtD
Amphetamine—Dyspnoea—Doxorubicin—stomach cancer	0.000152	0.00126	CcSEcCtD
Amphetamine—Somnolence—Doxorubicin—stomach cancer	0.000151	0.00125	CcSEcCtD
Amphetamine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000151	0.00125	CcSEcCtD
Amphetamine—Dyspepsia—Doxorubicin—stomach cancer	0.00015	0.00124	CcSEcCtD
Amphetamine—Decreased appetite—Doxorubicin—stomach cancer	0.000148	0.00122	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000147	0.00122	CcSEcCtD
Amphetamine—Fatigue—Doxorubicin—stomach cancer	0.000147	0.00121	CcSEcCtD
Amphetamine—Urticaria—Epirubicin—stomach cancer	0.000146	0.00121	CcSEcCtD
Amphetamine—Constipation—Doxorubicin—stomach cancer	0.000146	0.00121	CcSEcCtD
Amphetamine—Abdominal pain—Epirubicin—stomach cancer	0.000146	0.0012	CcSEcCtD
Amphetamine—Body temperature increased—Epirubicin—stomach cancer	0.000146	0.0012	CcSEcCtD
Amphetamine—Hypersensitivity—Methotrexate—stomach cancer	0.000145	0.0012	CcSEcCtD
Amphetamine—Asthenia—Methotrexate—stomach cancer	0.000141	0.00117	CcSEcCtD
Amphetamine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000139	0.00115	CcSEcCtD
Amphetamine—Hypersensitivity—Epirubicin—stomach cancer	0.000136	0.00112	CcSEcCtD
Amphetamine—Urticaria—Doxorubicin—stomach cancer	0.000135	0.00112	CcSEcCtD
Amphetamine—Body temperature increased—Doxorubicin—stomach cancer	0.000135	0.00111	CcSEcCtD
Amphetamine—Abdominal pain—Doxorubicin—stomach cancer	0.000135	0.00111	CcSEcCtD
Amphetamine—Diarrhoea—Methotrexate—stomach cancer	0.000135	0.00111	CcSEcCtD
Amphetamine—Asthenia—Epirubicin—stomach cancer	0.000132	0.00109	CcSEcCtD
Amphetamine—Dizziness—Methotrexate—stomach cancer	0.00013	0.00108	CcSEcCtD
Amphetamine—Diarrhoea—Epirubicin—stomach cancer	0.000126	0.00104	CcSEcCtD
Amphetamine—Hypersensitivity—Doxorubicin—stomach cancer	0.000125	0.00104	CcSEcCtD
Amphetamine—Vomiting—Methotrexate—stomach cancer	0.000125	0.00103	CcSEcCtD
Amphetamine—Rash—Methotrexate—stomach cancer	0.000124	0.00103	CcSEcCtD
Amphetamine—Dermatitis—Methotrexate—stomach cancer	0.000124	0.00103	CcSEcCtD
Amphetamine—Headache—Methotrexate—stomach cancer	0.000123	0.00102	CcSEcCtD
Amphetamine—Asthenia—Doxorubicin—stomach cancer	0.000122	0.00101	CcSEcCtD
Amphetamine—Dizziness—Epirubicin—stomach cancer	0.000122	0.00101	CcSEcCtD
Amphetamine—Vomiting—Epirubicin—stomach cancer	0.000117	0.000968	CcSEcCtD
Amphetamine—Nausea—Methotrexate—stomach cancer	0.000117	0.000967	CcSEcCtD
Amphetamine—Diarrhoea—Doxorubicin—stomach cancer	0.000117	0.000964	CcSEcCtD
Amphetamine—Rash—Epirubicin—stomach cancer	0.000116	0.00096	CcSEcCtD
Amphetamine—Dermatitis—Epirubicin—stomach cancer	0.000116	0.000959	CcSEcCtD
Amphetamine—Headache—Epirubicin—stomach cancer	0.000115	0.000954	CcSEcCtD
Amphetamine—Nateglinide—ALB—stomach cancer	0.000115	0.0173	CrCbGaD
Amphetamine—Dizziness—Doxorubicin—stomach cancer	0.000113	0.000932	CcSEcCtD
Amphetamine—Nausea—Epirubicin—stomach cancer	0.000109	0.000905	CcSEcCtD
Amphetamine—Vomiting—Doxorubicin—stomach cancer	0.000108	0.000896	CcSEcCtD
Amphetamine—Rash—Doxorubicin—stomach cancer	0.000107	0.000888	CcSEcCtD
Amphetamine—Dermatitis—Doxorubicin—stomach cancer	0.000107	0.000888	CcSEcCtD
Amphetamine—Headache—Doxorubicin—stomach cancer	0.000107	0.000883	CcSEcCtD
Amphetamine—Nausea—Doxorubicin—stomach cancer	0.000101	0.000837	CcSEcCtD
Amphetamine—SLC22A3—Metabolism—GSTT1—stomach cancer	3.29e-05	0.000383	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TP53—stomach cancer	3.28e-05	0.000382	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP2A6—stomach cancer	3.25e-05	0.000379	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CD44—stomach cancer	3.23e-05	0.000376	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PRKCB—stomach cancer	3.22e-05	0.000376	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALDH7A1—stomach cancer	3.22e-05	0.000375	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PLCE1—stomach cancer	3.22e-05	0.000375	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6ST—stomach cancer	3.21e-05	0.000374	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKR1C3—stomach cancer	3.16e-05	0.000368	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—UMPS—stomach cancer	3.09e-05	0.00036	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—APC—stomach cancer	3.08e-05	0.000359	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—HRAS—stomach cancer	3.08e-05	0.000359	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ENO1—stomach cancer	3.08e-05	0.000359	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—JUN—stomach cancer	3.04e-05	0.000354	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—IDH3B—stomach cancer	3.01e-05	0.000351	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SUCLG1—stomach cancer	3.01e-05	0.000351	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—IL6—stomach cancer	3e-05	0.00035	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—stomach cancer	2.99e-05	0.000348	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—MAPK3—stomach cancer	2.95e-05	0.000344	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCL8—stomach cancer	2.88e-05	0.000336	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—stomach cancer	2.88e-05	0.000336	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—MAPK8—stomach cancer	2.88e-05	0.000335	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—stomach cancer	2.87e-05	0.000334	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PDHA1—stomach cancer	2.87e-05	0.000334	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ECHS1—stomach cancer	2.87e-05	0.000334	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6R—stomach cancer	2.86e-05	0.000334	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—APOA1—stomach cancer	2.83e-05	0.00033	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—MAPK1—stomach cancer	2.81e-05	0.000328	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—EGFR—stomach cancer	2.81e-05	0.000327	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AGTR2—stomach cancer	2.8e-05	0.000327	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NDUFV1—stomach cancer	2.8e-05	0.000327	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NDUFS1—stomach cancer	2.8e-05	0.000327	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—WWOX—stomach cancer	2.78e-05	0.000324	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—F2R—stomach cancer	2.77e-05	0.000323	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPP2R1A—stomach cancer	2.74e-05	0.00032	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CD44—stomach cancer	2.73e-05	0.000318	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TYMP—stomach cancer	2.7e-05	0.000314	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—FADS1—stomach cancer	2.7e-05	0.000314	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR1A—stomach cancer	2.7e-05	0.000314	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GSTP1—stomach cancer	2.69e-05	0.000314	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—PIK3CA—stomach cancer	2.69e-05	0.000313	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SERPINE1—stomach cancer	2.68e-05	0.000313	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—HMOX1—stomach cancer	2.65e-05	0.000309	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—KRAS—stomach cancer	2.65e-05	0.000309	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ANXA1—stomach cancer	2.6e-05	0.000304	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRH4—stomach cancer	2.59e-05	0.000302	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—WIF1—stomach cancer	2.59e-05	0.000302	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—RHOA—stomach cancer	2.59e-05	0.000301	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NOS3—stomach cancer	2.56e-05	0.000298	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AGTR2—stomach cancer	2.54e-05	0.000297	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SREBF2—stomach cancer	2.53e-05	0.000294	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ADRB1—stomach cancer	2.52e-05	0.000294	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—F2R—stomach cancer	2.52e-05	0.000293	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—APOA1—stomach cancer	2.5e-05	0.000292	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—TYMS—stomach cancer	2.5e-05	0.000292	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PGLS—stomach cancer	2.5e-05	0.000291	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—BLVRB—stomach cancer	2.5e-05	0.000291	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—RORA—stomach cancer	2.5e-05	0.000291	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GSTM1—stomach cancer	2.47e-05	0.000288	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR1A—stomach cancer	2.45e-05	0.000285	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PIK3CA—stomach cancer	2.44e-05	0.000284	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—stomach cancer	2.4e-05	0.00028	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ERBB2—stomach cancer	2.39e-05	0.000279	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKAB1—stomach cancer	2.39e-05	0.000278	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPAP2A—stomach cancer	2.38e-05	0.000278	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ANXA1—stomach cancer	2.37e-05	0.000276	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALDOB—stomach cancer	2.34e-05	0.000273	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ERCC2—stomach cancer	2.33e-05	0.000271	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPP2R1A—stomach cancer	2.32e-05	0.000271	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RNF43—stomach cancer	2.31e-05	0.000269	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KISS1—stomach cancer	2.31e-05	0.000269	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.29e-05	0.000267	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ADRB1—stomach cancer	2.29e-05	0.000267	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—MAPK1—stomach cancer	2.29e-05	0.000267	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GSTP1—stomach cancer	2.28e-05	0.000265	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCL8—stomach cancer	2.27e-05	0.000265	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HRAS—stomach cancer	2.26e-05	0.000263	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—HMOX1—stomach cancer	2.25e-05	0.000262	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—stomach cancer	2.24e-05	0.000261	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CDKN1B—stomach cancer	2.22e-05	0.000258	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MTHFR—stomach cancer	2.19e-05	0.000255	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALOX5—stomach cancer	2.17e-05	0.000253	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL6—stomach cancer	2.16e-05	0.000252	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—DPYD—stomach cancer	2.14e-05	0.000249	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FBP1—stomach cancer	2.12e-05	0.000247	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NDUFA2—stomach cancer	2.12e-05	0.000247	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CKB—stomach cancer	2.12e-05	0.000247	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CA1—stomach cancer	2.12e-05	0.000247	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—TYMS—stomach cancer	2.12e-05	0.000247	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCND1—stomach cancer	2.12e-05	0.000247	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—JUN—stomach cancer	2.11e-05	0.000246	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GSTM1—stomach cancer	2.09e-05	0.000244	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FST—stomach cancer	2.06e-05	0.00024	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MMP9—stomach cancer	2.05e-05	0.000239	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CDKN1A—stomach cancer	2.05e-05	0.000239	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ADRB2—stomach cancer	2.04e-05	0.000238	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CAV1—stomach cancer	2.02e-05	0.000235	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—APOA1—stomach cancer	2.01e-05	0.000234	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HBEGF—stomach cancer	2.01e-05	0.000234	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TP53—stomach cancer	2.01e-05	0.000234	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAPK8—stomach cancer	2e-05	0.000233	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLIN2—stomach cancer	2e-05	0.000233	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—stomach cancer	1.98e-05	0.000231	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GAST—stomach cancer	1.98e-05	0.000231	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RGS2—stomach cancer	1.98e-05	0.000231	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ERCC2—stomach cancer	1.97e-05	0.000229	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CA2—stomach cancer	1.94e-05	0.000226	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NT5E—stomach cancer	1.89e-05	0.000221	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PGAM1—stomach cancer	1.89e-05	0.000221	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTT1—stomach cancer	1.89e-05	0.00022	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGG—stomach cancer	1.88e-05	0.000219	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ADRB2—stomach cancer	1.86e-05	0.000216	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MTHFR—stomach cancer	1.85e-05	0.000216	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—VEGFA—stomach cancer	1.84e-05	0.000215	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—HRAS—stomach cancer	1.84e-05	0.000214	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—IL6—stomach cancer	1.84e-05	0.000214	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—STAT3—stomach cancer	1.83e-05	0.000213	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PPP2R1A—stomach cancer	1.82e-05	0.000212	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKR1C3—stomach cancer	1.82e-05	0.000212	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKAA1—stomach cancer	1.81e-05	0.000211	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLCE1—stomach cancer	1.81e-05	0.00021	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALDH7A1—stomach cancer	1.81e-05	0.00021	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ENO1—stomach cancer	1.77e-05	0.000207	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARG—stomach cancer	1.77e-05	0.000207	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RBP4—stomach cancer	1.75e-05	0.000204	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCL8—stomach cancer	1.75e-05	0.000204	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAPK3—stomach cancer	1.74e-05	0.000203	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—UMPS—stomach cancer	1.73e-05	0.000202	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CAV1—stomach cancer	1.71e-05	0.000199	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOA1—stomach cancer	1.7e-05	0.000198	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MYC—stomach cancer	1.7e-05	0.000198	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAPK1—stomach cancer	1.66e-05	0.000193	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EGFR—stomach cancer	1.66e-05	0.000193	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PDHA1—stomach cancer	1.61e-05	0.000188	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ECHS1—stomach cancer	1.61e-05	0.000188	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—stomach cancer	1.59e-05	0.000186	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CD44—stomach cancer	1.57e-05	0.000183	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KRAS—stomach cancer	1.57e-05	0.000183	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NOS3—stomach cancer	1.52e-05	0.000178	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FADS1—stomach cancer	1.51e-05	0.000176	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TYMP—stomach cancer	1.51e-05	0.000176	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGTR2—stomach cancer	1.5e-05	0.000175	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HSPB1—stomach cancer	1.5e-05	0.000175	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARG—stomach cancer	1.5e-05	0.000175	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BMP2—stomach cancer	1.49e-05	0.000173	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—F2R—stomach cancer	1.49e-05	0.000173	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKR1C3—stomach cancer	1.46e-05	0.00017	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR1A—stomach cancer	1.45e-05	0.000169	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CA—stomach cancer	1.44e-05	0.000168	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SREBF2—stomach cancer	1.42e-05	0.000165	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PRKCB—stomach cancer	1.4e-05	0.000163	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—RORA—stomach cancer	1.4e-05	0.000163	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ANXA1—stomach cancer	1.4e-05	0.000163	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—stomach cancer	1.39e-05	0.000163	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TP53—stomach cancer	1.39e-05	0.000162	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRB1—stomach cancer	1.35e-05	0.000158	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—stomach cancer	1.35e-05	0.000157	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPP2R1A—stomach cancer	1.34e-05	0.000156	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HRAS—stomach cancer	1.33e-05	0.000155	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALDOB—stomach cancer	1.31e-05	0.000153	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTP1—stomach cancer	1.31e-05	0.000153	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HMOX1—stomach cancer	1.29e-05	0.000151	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RPS6—stomach cancer	1.29e-05	0.000151	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NOS3—stomach cancer	1.29e-05	0.00015	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—stomach cancer	1.28e-05	0.000149	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PRKCB—stomach cancer	1.27e-05	0.000148	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6ST—stomach cancer	1.27e-05	0.000148	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALOX5—stomach cancer	1.22e-05	0.000142	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TYMS—stomach cancer	1.22e-05	0.000142	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTM1—stomach cancer	1.2e-05	0.00014	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DPYD—stomach cancer	1.2e-05	0.00014	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HBEGF—stomach cancer	1.19e-05	0.000138	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—stomach cancer	1.18e-05	0.000138	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ERCC2—stomach cancer	1.13e-05	0.000132	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6R—stomach cancer	1.13e-05	0.000132	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—RHOA—stomach cancer	1.12e-05	0.000131	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRB2—stomach cancer	1.1e-05	0.000128	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PPP2R1A—stomach cancer	1.07e-05	0.000125	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—stomach cancer	1.06e-05	0.000124	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTT1—stomach cancer	1.06e-05	0.000124	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.05e-05	0.000122	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—RHOA—stomach cancer	1.02e-05	0.000119	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.02e-05	0.000119	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SMAD4—stomach cancer	9.98e-06	0.000116	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ENO1—stomach cancer	9.94e-06	0.000116	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL8—stomach cancer	9.87e-06	0.000115	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAV1—stomach cancer	9.82e-06	0.000114	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOA1—stomach cancer	9.8e-06	0.000114	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FYN—stomach cancer	9.47e-06	0.00011	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL8—stomach cancer	8.96e-06	0.000104	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGFR2—stomach cancer	8.89e-06	0.000104	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CD44—stomach cancer	8.82e-06	0.000103	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARG—stomach cancer	8.63e-06	0.000101	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CA—stomach cancer	8.58e-06	0.0001	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IRS2—stomach cancer	8.14e-06	9.49e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CAV1—stomach cancer	7.9e-06	9.2e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOA1—stomach cancer	7.88e-06	9.18e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—stomach cancer	7.76e-06	9.05e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCB—stomach cancer	7.51e-06	8.76e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	7.5e-06	8.74e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6ST—stomach cancer	7.48e-06	8.72e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NOS3—stomach cancer	7.43e-06	8.66e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTP1—stomach cancer	7.35e-06	8.57e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CA—stomach cancer	7.26e-06	8.46e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMOX1—stomach cancer	7.25e-06	8.45e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APC—stomach cancer	7.19e-06	8.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MAPK3—stomach cancer	6.89e-06	8.03e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TYMS—stomach cancer	6.84e-06	7.97e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—stomach cancer	6.79e-06	7.92e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTM1—stomach cancer	6.76e-06	7.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6R—stomach cancer	6.68e-06	7.78e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MAPK1—stomach cancer	6.55e-06	7.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—EGFR—stomach cancer	6.55e-06	7.64e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ERCC2—stomach cancer	6.35e-06	7.4e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	6.26e-06	7.3e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SERPINE1—stomach cancer	6.25e-06	7.29e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—KRAS—stomach cancer	6.19e-06	7.21e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RHOA—stomach cancer	6.03e-06	7.03e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—stomach cancer	5.97e-06	6.96e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOS3—stomach cancer	5.97e-06	6.96e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	5.69e-06	6.63e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ERBB2—stomach cancer	5.58e-06	6.51e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAV1—stomach cancer	5.51e-06	6.42e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOA1—stomach cancer	5.5e-06	6.41e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL8—stomach cancer	5.3e-06	6.17e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HRAS—stomach cancer	5.26e-06	6.13e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDKN1B—stomach cancer	5.17e-06	6.03e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—stomach cancer	5.04e-06	5.87e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCND1—stomach cancer	4.93e-06	5.75e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JUN—stomach cancer	4.92e-06	5.74e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARG—stomach cancer	4.84e-06	5.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—stomach cancer	4.79e-06	5.58e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	4.77e-06	5.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK8—stomach cancer	4.66e-06	5.43e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—stomach cancer	4.35e-06	5.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VEGFA—stomach cancer	4.3e-06	5.01e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STAT3—stomach cancer	4.26e-06	4.96e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CA—stomach cancer	4.18e-06	4.87e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NOS3—stomach cancer	4.16e-06	4.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK3—stomach cancer	4.07e-06	4.74e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MYC—stomach cancer	3.96e-06	4.61e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK1—stomach cancer	3.87e-06	4.51e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EGFR—stomach cancer	3.87e-06	4.51e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—stomach cancer	3.81e-06	4.44e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KRAS—stomach cancer	3.66e-06	4.26e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	3.36e-06	3.92e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TP53—stomach cancer	3.25e-06	3.79e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRAS—stomach cancer	3.11e-06	3.62e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—stomach cancer	2.97e-06	3.47e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.34e-06	2.73e-05	CbGpPWpGaD
